Portfolio company
NeuMoDx Molecular
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops automated molecular diagnostic systems and reagents for nucleic acid testing in clinical and hospital laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HandyLab
HandyLab manufactures molecular diagnostic systems for clinical laboratories to automate the detection of infectious diseases.
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
StatDx
This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.
QIAGEN NV
This company provides molecular testing technologies for healthcare professionals, academic researchers and pharmaceutical laboratories to facilitate clinical diagnostics and life sciences research.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Anvil Diagnostics
This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.
Qvella
Qvella develops molecular diagnostic platforms for rapid pathogen detection in whole blood samples to assist clinicians with infection management.